XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
Chronic pneumonitis
Last update 11/09/2026
May require prolonged corticosteroid therapy/ and/or mmunosuppression (PMID 32554618)
XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
Last update 11/09/2026
May require prolonged corticosteroid therapy/ and/or mmunosuppression (PMID 32554618)
Frequency - Incidence
Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic